ImpriMed's immunophenotyping services were developed in collaboration with experienced DVMs and are supported by established clinical/laboratory expertise and publications. Our immunophenotyping services are accredited by A2LA and operate under a robust quality management system with ongoing quality control, performance monitoring, and periodic review and update of our assays with our DVM advisors. Our services are routinely benchmarked against established veterinary reference laboratories and show a very high level of concordance.
ImpriMed has been providing laboratory services to veterinary oncologists for more than nine years, serving customers throughout the US, South Korea, Canada, and Europe. To date, we have performed 13,000+ flow cytometry tests and 9,000+ PARR assays. We consider our experience and knowledge in canine and feline lymphoma to be among the best worldwide.
Together, our expertise in this field, independent accreditation, extensive testing experience, benchmarking, and ongoing quality monitoring provide confidence that ImpriMed's diagnostic services are reliable, consistent, and clinically useful.